US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Freenome, Inc.

13.81

+0.30002.22%

Pre-market: 13.900.0900+0.65%08:06 EDT

Volume:735.07K

Turnover:10.15M

Market Cap:1.48B

PE:-200.14

High:14.13

Open:13.33

Low:13.33

Close:13.51

52wk High:14.47

52wk Low:9.95

Shares:107.00M

Float Shares:76.43M

Volume Ratio:0.62

T/O Rate:0.96%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0690

EPS(LYR):-8.2800

ROE:--

ROA:--

PB:-1.06

PE(LYR):-1.67

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Freenome, Inc.

Exchange:

NASDAQ

Establishment Date:

2014

Employees:

378

Office Location:

3300 Marina Boulevard,Brisbane,California,United States

Website:

http://www.freenome.com

Zip Code:

94005

Phone:

Fax:

- -

Introduction:

Freenome, Inc. was incorporated in the Cayman Islands on March 22, 2024, and reincorporated in Delaware on July 21, 2026. The company is a development-stage early cancer detection company dedicated to developing blood-based screening tests that leverage its proprietary AI and machine learning multi-omics technology platform to transform the detection of multiple cancers and ultimately various diseases. The company is developing a portfolio of blood-based cancer screening tests, including its lead product for which a premarket approval application has been submitted to the FDA, an improved version, and a blood-based lung cancer detection test. Freenome has also initiated a clinical study to support the regulatory submission for its lung cancer detection test.

Directors

Name

Position

Aaron Elliott

Chief Executive Officer and Director

Ann Costello

Director

Carole Nuechterlein

Director

Deepika Pakianathan

Director

Douglas M. VanOort

Director

Peter Kolchinsky

Director

Randal Scott

Director

Shareholders

Name

Position

Aaron Elliott

Chief Executive Officer and Director

Linh H. Le

Chief Financial Officer

Cheng Ho Jimmy Lin

Chief Scientific Officer

Riley Ennis

Chief Product Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/FRNM/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FRNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRNM\",,,,,undefined,":{"symbol":"FRNM","market":"US","secType":"STK","nameCN":"Freenome, Inc.","latestPrice":13.81,"timestamp":1787342400000,"preClose":13.51,"halted":0,"volume":735071,"hourTrading":{"tag":"盘前","latestPrice":13.9,"preClose":13.81,"latestTime":"08:06 EDT","volume":116,"amount":1602.2999960000002,"timestamp":1787573191471,"change":0.09,"changeRate":0.006517,"amplitude":0.007241},"delay":0,"changeRate":0.022205773501110342,"floatShares":76431399,"shares":107000000,"eps":-0.069,"marketStatus":"Pre-Mkt","change":0.3,"latestTime":"08-24 08:10:09 EDT","open":13.33,"high":14.13,"low":13.33,"amount":10148577.669105,"amplitude":0.059215,"askPrice":13.95,"askSize":87,"bidPrice":11.85,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.069,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1718164800000,"exchange":"NASDAQ","adjPreClose":13.81,"preHourTrading":{"tag":"盘前","latestPrice":13.9,"preClose":13.81,"latestTime":"08:06 EDT","volume":116,"amount":1602.2999960000002,"timestamp":1787573191471,"change":0.09,"changeRate":0.006517,"amplitude":0.007241},"postHourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"19:30 EDT","volume":144,"amount":1996.76,"timestamp":1787355007346,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6158317994619813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRNM\",,,,,undefined,":{"symbol":"FRNM","floatShares":76431399,"roa":"--","roe":"--","lyrEps":-8.279999,"volumeRatio":0.6158317994619813,"shares":107000000,"dividePrice":0,"high":14.13,"amplitude":0.059215,"preClose":13.51,"low":13.33,"week52Low":9.95,"pbRate":"-1.06","psRate":"41.73","week52High":14.47,"institutionHeld":0,"latestPrice":13.81,"committee":0.069519,"eps":-0.069,"divideRate":0,"volume":735071,"delay":0,"ttmEps":-0.069,"open":13.33,"prevYearClose":13.03,"prevWeekClose":13.81,"prevMonthClose":11.15,"prevQuarterClose":10.88,"fiveDayClose":11.56,"twentyDayClose":11.24,"sixtyDayClose":11.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-15","symbol":"FRNM","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784088000000,"reportTimeType":"pre","actualEps":-0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FRNM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FRNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FRNM","date":"2026-08-21","current":-200.144928,"percent":0.055556,"low":-6.835818,"twenty":-6.21894,"median":-5.707382,"eighty":-5.471664,"high":-5.010259,"avg":-5.811647,"sd":0.529714,"marketCap":1524707608},"quantilePoints":[{"date":"2026-07-31","current":-5.010259,"twenty":-5.523823,"median":-5.223408,"eighty":-5.031323,"marketCap":1127448482},{"date":"2026-08-07","current":-5.471664,"twenty":-5.549902,"median":-5.471664,"eighty":-5.259016,"marketCap":1231277572},{"date":"2026-08-14","current":-5.822733,"twenty":-5.804678,"median":-5.556923,"eighty":-5.443578,"marketCap":1310277966},{"date":"2026-08-21","current":-6.775635,"twenty":-6.21894,"median":-5.707382,"eighty":-5.471664,"marketCap":1524707608}],"updateTime":1787570495379},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":558895568,"yearFounded":2014,"employeeNum":378,"address":"3300 Marina Boulevard,Brisbane,California,United States","zipCode":"94005","officePhone":"(650) 446-6630","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.freenome.com","stockEarnings":[{"period":"1week","weight":0.1946},{"period":"1month","weight":0.051},{"period":"3month","weight":0.2363},{"period":"6month","weight":0.036},{"period":"1year","weight":0.3065},{"period":"ytd","weight":0.0599}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Freenome, Inc. was incorporated in the Cayman Islands on March 22, 2024, and reincorporated in Delaware on July 21, 2026. The company is a development-stage early cancer detection company dedicated to developing blood-based screening tests that leverage its proprietary AI and machine learning multi-omics technology platform to transform the detection of multiple cancers and ultimately various diseases. The company is developing a portfolio of blood-based cancer screening tests, including its lead product for which a premarket approval application has been submitted to the FDA, an improved version, and a blood-based lung cancer detection test. Freenome has also initiated a clinical study to support the regulatory submission for its lung cancer detection test.","exchange":"NASDAQ","name":"Freenome, Inc.","nameEN":"Freenome, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FRNM\",market:\"US\",,,undefined,":{"directors":[{"name":"Aaron Elliott","position":"Chief Executive Officer and Director"},{"name":"Ann Costello","position":"Director"},{"name":"Carole Nuechterlein","position":"Director"},{"name":"Deepika Pakianathan","position":"Director"},{"name":"Douglas M. VanOort","position":"Director"},{"name":"Peter Kolchinsky","position":"Director"},{"name":"Randal Scott","position":"Director"}],"executives":[{"name":"Aaron Elliott","position":"Chief Executive Officer and Director"},{"name":"Linh H. Le","position":"Chief Financial Officer"},{"name":"Cheng Ho Jimmy Lin","position":"Chief Scientific Officer"},{"name":"Riley Ennis","position":"Chief Product Officer"}]}}}